Phio Pharmaceuticals (PHIO) Restructuring Costs (2011 - 2013)
Phio Pharmaceuticals' (PHIO) quarterly Restructuring Costs came in at $473000.0 in Q1 2013, down 29.82% YoY from $674000.0 in Q1 2012, and down 27.23% on a QoQ basis from $650000.0 in Q4 2012.
Phio Pharmaceuticals (PHIO) Restructuring Costs (2011 - 2013) Analysis & Trends
Phio Pharmaceuticals (PHIO) has 3 years of Restructuring Costs data on file, last reported at $473000.0 in Q1 2013.
- Quarterly Restructuring Costs fell 29.82% year-over-year to $473000.0 in Q1 2013, while the trailing twelve-month figure through Mar 2013 was $2.2 million (changed N/A YoY) and the FY2012 annual result came in at $2.2 million, down 50.15% from the prior year.
- Restructuring Costs retreated to $473000.0 in Q1 2013, from $650000.0 in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $830000.0 in Q4 2011 to a low of $387000.0 in Q3 2012.
- A 3-year average of $624000.0 and a median of $662000.0 in 2012 frame the typical range for Restructuring Costs.
- The widest YoY moves for Restructuring Costs: up 21.69% in 2012, down 46.99% in 2012.
- Tracing PHIO's Restructuring Costs over 3 years: stood at $830000.0 in 2011, then retreated by 21.69% to $650000.0 in 2012, then slipped by 27.23% to $473000.0 in 2013.
- The last three Restructuring Costs figures came in at $473000.0 (Q1 2013), $650000.0 (Q4 2012), and $387000.0 (Q3 2012), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.69 Bn | 130.84 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.29 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.79 Bn | 59.60 Bn | 1.37 Bn |
| 4 | Moderna | 59.44 Bn | 54.31 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.92 Bn | 27.61 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.10 Bn | 9.71 Bn | 668.28 Mn |
| 8 | Insmed | 27.33 Bn | 26.17 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.00 Bn | 26.17 Bn | - |
| 10 | Phio Pharmaceuticals | 13.91 Mn | 13.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 473,000.00 |
| Dec 31, 2012 | 650,000.00 |
| Sep 30, 2012 | 387,000.00 |
| Mar 31, 2012 | 674,000.00 |
| Dec 31, 2011 | 830,000.00 |
| Sep 30, 2011 | 730,000.00 |